Evaluation of Percutaneous Cryotherapy in the Treatment of Plexiform Neurofibromas and Unresectable Neurofibromas in Neurofibromatosis Type 1

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 14, 2022

Primary Completion Date

February 7, 2026

Study Completion Date

February 7, 2027

Conditions
NeurofibromaNeurofibroma, Plexiform
Interventions
DEVICE

Cryotherapy

The cryotherapy treatment lasts approximately 30 minutes during which two 10-minute freezing cycles are performed, separated by a reheating phase. During the freezing phases, the temperature is lowered below -40°C in the ablation zone, a temperature that is lethal for the cells.

Trial Locations (1)

69373

RECRUITING

Centre Leon Berard, Lyon

All Listed Sponsors
lead

Centre Leon Berard

OTHER